| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.01 |